Article

Refractec files PMA for presbyopia procedure

Irvine, CA-Refractec Inc. has filed its pre-market approval application with the FDA for a conductive keratoplasty (CK) procedure designed for patients with presbyopia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.